2024-04-01 2025-03-31 false Capium Accounts Production 1.1 07600026 2024-04-01 2025-03-31 07600026 bus:AbridgedAccounts 2024-04-01 2025-03-31 07600026 bus:FRS102 2024-04-01 2025-03-31 07600026 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 07600026 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07600026 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07600026 2024-04-01 2025-03-31 07600026 2025-03-31 07600026 bus:RegisteredOffice 2024-04-01 2025-03-31 07600026 core:WithinOneYear 2025-03-31 07600026 core:AfterOneYear 2025-03-31 07600026 1 2024-04-01 2025-03-31 07600026 bus:Director1 2024-04-01 2025-03-31 07600026 bus:Director1 2025-03-31 07600026 bus:Director1 2023-04-01 2024-03-31 07600026 2023-04-01 07600026 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 07600026 2023-04-01 2024-03-31 07600026 2024-03-31 07600026 core:WithinOneYear 2024-03-31 07600026 core:AfterOneYear 2024-03-31 07600026 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 07600026 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 07600026 bus:OrdinaryShareClass1 2025-03-31 07600026 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 07600026 bus:OrdinaryShareClass1 2024-03-31 07600026 core:LandBuildings 2024-04-01 2025-03-31 07600026 core:LandBuildings 2025-03-31 07600026 core:LandBuildings 2024-03-31 07600026 core:PlantMachinery 2024-04-01 2025-03-31 07600026 core:PlantMachinery 2025-03-31 07600026 core:PlantMachinery 2024-03-31 07600026 core:FurnitureFittings 2024-04-01 2025-03-31 07600026 core:FurnitureFittings 2025-03-31 07600026 core:FurnitureFittings 2024-03-31 07600026 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 07600026 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 07600026 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 07600026 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 07600026 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 07600026 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 07600026 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 07600026 core:Non-currentFinancialInstruments 2025-03-31 07600026 core:Non-currentFinancialInstruments 2024-03-31 07600026 core:ShareCapital 2025-03-31 07600026 core:ShareCapital 2024-03-31 07600026 core:RetainedEarningsAccumulatedLosses 2025-03-31 07600026 core:RetainedEarningsAccumulatedLosses 2024-03-31 07600026 dpl:Item1 2024-04-01 07600026 dpl:Item1 2025-03-31 07600026 dpl:Item1 2023-04-01 07600026 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07600026
England and Wales

 

 

 

AUTONOMY HEALTHCARE LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

Autonomy Healthcare Limited
Contents Page
For the year ended 31 March 2025
Chartered Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of Autonomy Healthcare Limited for the year ended 31 March 2025.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Autonomy Healthcare Limited for the year ended 31 March 2025 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/members/regulations-standards-and-guidance.
This report is made solely to the Board of Directors of Autonomy Healthcare Limited , as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of Autonomy Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of Autonomy Healthcare Limited , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Autonomy Healthcare Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Autonomy Healthcare Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Autonomy Healthcare Limited . You consider that Autonomy Healthcare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Autonomy Healthcare Limited . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts

31 March 2025.



....................................................
CBS (Nottingham) Ltd
61 Elmswood Gardens
Nottingham
NG5 4AY
30 December 2025
1
 
 		 Notes
 		 2025
£		   2024
£
Fixed assets      
Tangible fixed assets 3 490,047    500,963 
490,047    500,963 
Current assets      
Debtors 354,693    443,841 
Cash at bank and in hand 87,872    18,756 
442,565    462,597 
Creditors: amount falling due within one year (306,397)   (364,340)
Net current assets 136,168    98,257 
 
Total assets less current liabilities 626,215    599,220 
Provisions for liabilities (6,998)   (6,998)
Net assets 619,217    592,222 
 

Capital and reserves 		     
Called up share capital 4 100    100 
Profit and loss account 619,117    592,122 
Shareholders' funds 619,217    592,222 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 30 December 2025 and were signed by:


-------------------------------
Steve Koban
Director
2
General Information
Autonomy Healthcare Limited is a private company, limited by shares, registered in England and Wales, registration number 07600026, registration address 17 St. Christophers Way, , Pride Park, , Derby, DE24 8JY.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced services provided by the company.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 25% pa Straight Line
Fixtures and Fittings 25% pa Straight Line
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees

Average number of employees during the year was 44 (2024 : 48).
3.

Tangible fixed assets

Cost or valuation Land and Buildings   Plant and Machinery   Fixtures and Fittings   Total
  £   £   £   £
At 01 April 2024 519,249    22,731    107,545    649,525 
Additions -    -    1,829    1,829 
Disposals -    -    -    - 
Revaluations (37,222)   -    -    (37,222)
At 31 March 2025 482,027    22,731    109,374    614,132 
Depreciation
At 01 April 2024 -    17,048    94,292    111,340 
Charge for year -    5,682    7,063    12,745 
On disposals -    -    -    - 
At 31 March 2025 -    22,730    101,355    124,085 
Net book values
Closing balance as at 31 March 2025 482,027    1    8,019    490,047 
Opening balance as at 01 April 2024 482,027    5,683    13,253    500,963 


4.

Share Capital

Allotted, called up and fully paid
2025
£		   2024
£
100 Ordinary shares of £1.00 each 100    100 
100    100 

3